Description

Depo-Provera (medroxyprogesterone) suspension 150 mg/1 ml. vial

Ingredients

Depo-Provera contains medroxyprogesterone acetate, a synthetic progestin.

Dosage

Depo-Provera is administered as a 150 mg/1 ml. vial injection every 3 months.

Indications

Depo-Provera is indicated for contraception and the treatment of endometriosis and certain types of cancer.

Contraindications

Depo-Provera should not be used in individuals with a history of breast cancer, liver disease, or blood clots.

Directions

Depo-Provera should be administered by a healthcare professional via intramuscular injection.

Scientific Evidence

Studies have shown that Depo-Provera is highly effective in preventing pregnancy with a failure rate of less than 1% when used correctly.

Additional Information

It is important to note that Depo-Provera does not protect against sexually transmitted infections.

Depo-Provera works by inhibiting ovulation and thickening cervical mucus, making it difficult for sperm to reach the egg. It also alters the endometrium, reducing the likelihood of implantation.

Research has shown that Depo-Provera may have potential benefits beyond contraception, such as reducing the risk of endometrial cancer and providing relief for women with endometriosis.